Reducing blood sugar spikes to treat early type 2 diabetes
Treating early type 2 diabetes by reducing postprandial glucose excursions: A paradigm shift in lifestyle modification
This study is looking for 200 adults who have just been diagnosed with type 2 diabetes to try a new way to manage their blood sugar after meals, using a home program that could be easier and cheaper than taking medication.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project ID | NIH-11113804 on NIH RePORTER |
What this research studies
This research investigates a new approach to managing early type 2 diabetes by focusing on reducing spikes in blood sugar after meals. It aims to provide a lifestyle intervention that is more sustainable and less expensive than traditional medication regimens. The study will involve 200 adults who have recently been diagnosed with type 2 diabetes and have not yet started medication, allowing them to participate in a self-administered program from home. Participants will be randomized to receive either individualized medication management or a program designed to minimize post-meal blood glucose excursions.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults who have recently been diagnosed with type 2 diabetes and have not yet begun taking diabetes medication.
Not a fit: Patients who have been diagnosed with type 2 diabetes for an extended period or those already on diabetes medication may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and manageable treatment options for individuals with early type 2 diabetes.
How similar studies have performed: Previous research has shown promising results with similar lifestyle interventions, indicating potential for success in this approach.
Where this research is happening
Charlottesville, United States
- University of Virginia — Charlottesville, United States (Active)
Researchers
- Principal investigator: Fabris, Chiara — University of Virginia
- Study coordinator: Fabris, Chiara
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.